Axel Bolte - Feb 24, 2022 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
Chief Executive Officer, Director
Signature
/s/ Axel Bolte
Stock symbol
INZY
Transactions as of
Feb 24, 2022
Transactions value $
$0
Form type
4
Date filed
2/28/2022, 06:47 AM
Previous filing
Jun 25, 2021
Next filing
Apr 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INZY Stock option (right to buy) Award $0 +275K $0.00 275K Feb 24, 2022 Common Stock 275K $5.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on February 24, 2022. The shares underlying the option are scheduled to vest in equal monthly installments from February 24, 2022 through February 24, 2026.